PHASEBIO PHARMA Net Income 2018-2020 | PHAS

PHASEBIO PHARMA net income from 2018 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
PHASEBIO PHARMA Annual Net Income
(Millions of US $)
2019 $-39
2018 $-24
2017 $-10
PHASEBIO PHARMA Quarterly Net Income
(Millions of US $)
2020-06-30 $-28
2020-03-31 $-15
2019-12-31 $-11
2019-09-30 $-11
2019-06-30 $-9
2019-03-31 $-7
2018-12-31 $-5
2018-09-30 $-8
2018-06-30 $-7
2018-03-31 $-4
2017-12-31
2017-09-30 $-3
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.103B $0.002B
PhaseBio Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary indications. The company's product consists of PB2452, a novel reversal agent for the antiplatelet drug ticagrelor and PB1046, a once-weekly fusion protein for the treatment of pulmonary arterial hypertension, which are in clinical stage. PhaseBio Pharmaceuticals Inc. is based in Malvern, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $148.860B 16.17
Bristol Myers Squibb (BMY) United States $136.418B 10.50
CSL (CSLLY) Australia $94.077B 0.00
Gilead Sciences (GILD) United States $79.223B 11.41
Vertex Pharmaceuticals (VRTX) United States $70.878B 39.55
Regeneron Pharmaceuticals (REGN) United States $59.556B 22.77
Illumina (ILMN) United States $45.126B 52.47
Biogen (BIIB) United States $44.910B 7.69
Seattle Genetics (SGEN) United States $34.049B 0.00
Moderna (MRNA) United States $27.917B 0.00
BeiGene (BGNE) Cayman Islands $25.894B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.080B 10.45
Genmab (GMAB) Denmark $23.946B 15.13
Genmab (GNMSF) Denmark $22.650B 5.22
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.204B 0.00
Immunomedics (IMMU) United States $19.654B 0.00
Incyte (INCY) United States $19.626B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.885B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.038B 37.53
BioNTech SE (BNTX) Germany $15.664B 0.00
Exact Sciences (EXAS) United States $15.310B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioMarin Pharmaceutical (BMRN) United States $13.797B 100.11
ARGENX SE-ADR (ARGX) Netherlands $12.340B 0.00
QIAGEN (QGEN) Netherlands $11.902B 30.21
Guardant Health (GH) United States $11.114B 0.00
Sarepta Therapeutics (SRPT) United States $11.025B 0.00
Bio-Techne Corp (TECH) United States $9.552B 65.54
Galapagos (GLPG) Belgium $9.260B 33.55
Ascendis Pharma (ASND) Denmark $8.155B 0.00
Repligen (RGEN) United States $7.746B 122.95
Exelixis (EXEL) United States $7.555B 27.47
Mirati Therapeutics (MRTX) United States $7.396B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.274B 18.10
MyoKardia (MYOK) United States $7.226B 0.00
Acceleron Pharma (XLRN) United States $6.740B 0.00
Novavax (NVAX) United States $6.639B 0.00
Adaptive Biotechnologies (ADPT) United States $6.604B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.504B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.247B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.869B 181.83
Emergent Biosolutions (EBS) United States $5.469B 21.66
Blueprint Medicines (BPMC) United States $5.124B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.980B 0.00
China Biologic Products (CBPO) China $4.375B 25.97
Vir Biotechnology (VIR) United States $4.362B 0.00
Arena Pharmaceuticals (ARNA) United States $4.311B 0.00
MorphoSys AG (MOR) Germany $4.130B 54.12
NeoGenomics (NEO) United States $4.074B 1229.67
Legend Biotech (LEGN) United States $3.990B 0.00
Denali Therapeutics (DNLI) United States $3.797B 0.00
Amicus Therapeutics (FOLD) United States $3.654B 0.00
Halozyme Therapeutics (HALO) United States $3.601B 0.00
Bluebird Bio (BLUE) United States $3.573B 0.00
Fate Therapeutics (FATE) United States $3.471B 0.00
Twist Bioscience (TWST) United States $3.393B 0.00
Global Blood Therapeutics (GBT) United States $3.383B 0.00
Reata Pharmaceuticals (RETA) United States $3.274B 0.00
Insmed (INSM) United States $3.262B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.892B 0.00
Sorrento Therapeutics (SRNE) United States $2.699B 0.00
I-Mab (IMAB) China $2.684B 0.00
Alkermes (ALKS) Ireland $2.635B 55.23
PHARMA MAR SA (PHMMF) Spain $2.304B 0.00
Mesoblast (MESO) Australia $2.180B 0.00
Seres Therapeutics (MCRB) United States $2.159B 0.00
Zymeworks (ZYME) Canada $2.125B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.049B 0.00
Eidos Therapeutics (EIDX) United States $1.949B 0.00
Inovio Pharmaceuticals (INO) United States $1.943B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Editas Medicine (EDIT) United States $1.747B 0.00
Intra-Cellular Therapies (ITCI) United States $1.727B 0.00
Revance Therapeutics (RVNC) United States $1.657B 0.00
UniQure (QURE) Netherlands $1.637B 0.00
Amarin (AMRN) Ireland $1.623B 0.00
Viela Bio (VIE) United States $1.537B 0.00
Ligand Pharmaceuticals (LGND) United States $1.533B 51.80
Zealand Pharma (ZEAL) Denmark $1.527B 0.00
Cytokineticsorporated (CYTK) United States $1.526B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.367B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.340B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Sangamo Therapeutics (SGMO) United States $1.332B 0.00
Coherus BioSciences (CHRS) United States $1.311B 7.64
Mersana Therapeutics (MRSN) United States $1.274B 0.00
Beam Therapeutics (BEAM) United States $1.274B 0.00
Epizyme (EPZM) United States $1.211B 0.00
Intellia Therapeutics (NTLA) United States $1.168B 0.00
Arcus Biosciences (RCUS) United States $1.112B 0.00
Compugen (CGEN) Israel $1.112B 0.00
NGM Biopharmaceuticals (NGM) United States $1.095B 0.00
Genetron Holdings (GTH) China $1.055B 0.00
Alcobra (ARCT) United States $1.046B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.042B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.038B 0.00
REGENXBIO (RGNX) United States $1.027B 0.00
Castle Biosciences (CSTL) United States $1.013B 0.00
Athenex (ATNX) United States $0.989B 0.00
Myriad Genetics (MYGN) United States $0.974B 0.00
Retrophin (RTRX) United States $0.940B 0.00
Heska (HSKA) United States $0.933B 0.00
Arvinas (ARVN) United States $0.926B 0.00
Vericel (VCEL) United States $0.838B 0.00
Morphic Holding (MORF) United States $0.838B 0.00
Alector (ALEC) United States $0.835B 0.00
Adverum Biotechnologies (ADVM) United States $0.831B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.819B 0.00
Pliant Therapeutics (PLRX) United States $0.803B 0.00
Cellectis S.A (CLLS) France $0.786B 0.00
NantKwest (NK) United States $0.749B 0.00
Agenus (AGEN) United States $0.734B 0.00
Protagonist Therapeutics (PTGX) United States $0.720B 0.00
Pharming Group (PHGUF) Netherlands $0.704B 16.07
MiMedx (MDXG) United States $0.701B 0.00
Codexis (CDXS) United States $0.694B 0.00
Kadmon Holdings (KDMN) United States $0.671B 0.00
VBI Vaccines (VBIV) United States $0.661B 0.00
Frequency Therapeutics (FREQ) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Intrexon (PGEN) United States $0.603B 0.00
Cara Therapeutics (CARA) United States $0.597B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Northwest Biotherapeutics (NWBO) United States $0.593B 0.00
Celldex Therapeutics (CLDX) United States $0.580B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.569B 0.00
Forte Biosciences (FBRX) United States $0.544B 0.00
Geron (GERN) United States $0.540B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.540B 0.00
Scholar Rock Holding (SRRK) United States $0.528B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.528B 4.62
Autolus Therapeutics (AUTL) United Kingdom $0.524B 0.00
Clovis Oncology (CLVS) United States $0.514B 0.00
IVERIC Bio (ISEE) United States $0.505B 0.00
Anika Therapeutics (ANIK) United States $0.503B 21.98
Aquinox Pharmaceuticals (NLTX) United States $0.501B 0.00
Albireo Pharma (ALBO) United States $0.500B 0.00
MeiraGTx Holdings (MGTX) United States $0.495B 0.00
Cel-Sci (CVM) United States $0.492B 0.00
Dynavax Technologies (DVAX) United States $0.473B 0.00
Cue Biopharma (CUE) United States $0.444B 0.00
Pfenex (PFNX) United States $0.437B 0.00
Avid Bioservices (CDMO) United States $0.431B 0.00
MannKind (MNKD) United States $0.431B 0.00
Amryt Pharma (AMYT) United Kingdom $0.424B 0.00
Kala Pharmaceuticals (KALA) United States $0.420B 0.00
Syros Pharmaceuticals (SYRS) United States $0.405B 0.00
UROGEN PHARMA (URGN) United States $0.403B 0.00
AnaptysBio (ANAB) United States $0.403B 0.00
Starpharma Holdings (SPHRY) Australia $0.403B 0.00
Puma Biotechnology (PBYI) United States $0.400B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.400B 0.00
Prothena (PRTA) Ireland $0.399B 0.00
Trevena (TRVN) United States $0.394B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.387B 0.00
Athersys (ATHX) United States $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.376B 26.64
Kamada (KMDA) Israel $0.372B 17.79
Sutro Biopharma (STRO) United States $0.361B 0.00
PDL BioPharma (PDLI) United States $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
Fortress Biotech (FBIO) United States $0.356B 0.00
IBio (IBIO) United States $0.354B 0.00
AC Immune SA (ACIU) Switzerland $0.350B 0.00
Merus (MRUS) Netherlands $0.349B 0.00
ANI Pharmaceuticals (ANIP) United States $0.347B 8.20
Bicycle Therapeutics (BCYC) United Kingdom $0.337B 0.00
Cardiff Oncology (CRDF) United States $0.336B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.324B 0.00
Precision BioSciences (DTIL) United States $0.322B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.316B 0.00
WAVE Life Sciences (WVE) Singapore $0.309B 0.00
CytomX Therapeutics (CTMX) United States $0.307B 0.00
Innate Pharma S.A (IPHA) France $0.303B 0.00
OSMOTICA PHARM (OSMT) United States $0.279B 0.00
Pluristem Therapeutics (PSTI) Israel $0.269B 0.00
Selecta Biosciences (SELB) United States $0.266B 0.00
Prometic Life Sciences (LMNL) Canada $0.263B 0.00
Affimed (AFMD) Germany $0.258B 0.00
Arbutus Biopharma (ABUS) United States $0.253B 0.00
ChromaDex (CDXC) United States $0.247B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.246B 0.00
NextCure (NXTC) United States $0.242B 0.00
TELA Bio (TELA) United States $0.238B 0.00
Spero Therapeutics (SPRO) United States $0.236B 0.00
Dyadic (DYAI) United States $0.208B 0.00
XOMA (XOMA) United States $0.208B 0.00
HOOKIPA Pharma (HOOK) United States $0.207B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
Cyclerion Therapeutics (CYCN) United States $0.206B 0.00
Verastem (VSTM) United States $0.205B 0.00
GENFIT S.A (GNFT) France $0.199B 0.00
Aduro Biotech (ADRO) United States $0.197B 0.00
DBV Technologies S.A (DBVT) France $0.190B 0.00
CorMedix Inc (CRMD) United States $0.188B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Liquidia Technologies (LQDA) United States $0.186B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.179B 0.00
Biofrontera AG (BFRA) Germany $0.176B 0.00
Five Prime Therapeutics (FPRX) United States $0.172B 0.00
Cerecor (CERC) United States $0.170B 0.00
Theratechnologies (THTX) Canada $0.170B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Eton Pharmaceuticals (ETON) United States $0.166B 0.00
SESEN BIO, INC (SESN) United States $0.164B 0.00
Checkpoint Therapeutics (CKPT) United States $0.161B 0.00
Aptinyx (APTX) United States $0.159B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.154B 7.20
VolitionRX (VNRX) United States $0.154B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.153B 0.00
Exicure (XCUR) United States $0.153B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AquaBounty Technologies (AQB) United States $0.144B 0.00
Aytu Bioscience (AYTU) United States $0.144B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.140B 0.00
Celyad SA (CYAD) Belgium $0.138B 0.00
Bellus Health (BLU) Canada $0.137B 0.00
VTv Therapeutics (VTVT) United States $0.126B 0.00
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
Protalix BioTherapeutics (PLX) Israel $0.126B 0.00
Cidara Therapeutics (CDTX) United States $0.122B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.118B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Strongbridge Biopharma (SBBP) United States $0.114B 0.00
Orgenesis (ORGS) United States $0.111B 5.66
Palatin Technologies (PTN) United States $0.109B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.108B 0.00
Evogene (EVGN) Israel $0.102B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
Enzo Biochem (ENZ) United States $0.101B 0.00
Gritstone Oncology (GRTS) United States $0.100B 0.00
Unum Therapeutics (UMRX) United States $0.099B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Windtree Therapeutics (WINT) United States $0.093B 0.00
Oncobiologics (OTLK) United States $0.092B 0.00
Bionano Genomics (BNGO) United States $0.090B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
Abeona Therapeutics (ABEO) United States $0.086B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.076B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Adocia (ADOCY) France $0.067B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.063B 0.00
Curis (CRIS) United States $0.063B 0.00
Appili Therapeutics (APLIF) Canada $0.062B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
TRACON Pharmaceuticals (TCON) United States $0.061B 0.00
AmpliPhi Biosciences (ARMP) United States $0.060B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.057B 0.00
Soligenix (SNGX) United States $0.053B 0.00
Organovo Holdings (ONVO) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Novogen (KZIA) Australia $0.049B 0.00
Cocrystal Pharma (COCP) United States $0.048B 0.00
CollPlant Holdings (CLGN) Israel $0.047B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 67.50
Genetic Technologies (GENE) Australia $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Signal Genetics (MGEN) United States $0.044B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
AnPac Bio-Medical Science (ANPC) China $0.042B 0.00
Apricus Biosciences (SEEL) United States $0.042B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
OvaScience (MLND) United States $0.031B 0.00
ATyr Pharma (LIFE) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Advaxis (ADXS) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Acorda Therapeutics (ACOR) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Celsion (CLSN) United States $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Spherix (AIKI) United States $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00